Similar to our findings, research in pancreatic cancer has shown that ONECUT3 affects tumor glycolysis and inhibits CD8 + T cell infiltration, as well as the efficacy of anti-PD-1 therapy [44]. Here, ONECUT3 is linked to neoplasm.